查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2000444

腦機介面市場預測至2034年：按產品、組件、技術、適應症、最終用戶和地區分類的全球分析

Neuro-Restorative Brain-Computer Interface Market Forecasts to 2034 - Global Analysis By Product, By Component, By Technology, By Indication, By End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球神經復健腦機介面 (BCI) 市場預計將在 2026 年達到 3 億美元，並在預測期內以 15.9% 的複合年成長率成長，到 2034 年達到 9.6 億美元。

神經復健腦機介面（BCI）是一種在大腦和外部裝置之間建立直接通訊路徑的技術，旨在恢復或增強神經功能。這些系統能夠解讀神經訊號並將其轉換為控制義肢、電腦或治療性刺激器的指令。 BCI旨在幫助患有癱瘓、脊髓損傷和神經退化性疾病等神經系統疾病的患者。透過實現神經復健和恢復喪失的功能，神經復健BCI能夠改善患者的行動能力、溝通能力和獨立生活能力，同時推動神經技術和腦健康領域的研究。

神經介面技術的進步

神經訊號擷取、處理演算法和電極設計的不斷改進提升了腦機介面（BCI）系統的性能和可靠性。這些創新使得人腦與外部設備之間的通訊更加精準。現代BCI系統正日益廣泛應用於輔助治療癱瘓、脊髓損傷和神經退化性疾病等神經系統疾病患者。研究人員也致力於開發微創無線神經介面，以提高患者的舒適度和易用性。隨著技術的不斷進步，再生型BCI解決方案的有效性和普及率可望顯著提升。

腦機介面設備高成本

開發先進的神經介面系統需要精密的硬體、專用材料和複雜的軟體演算法。此外，臨床試驗和監管核准流程進一步增加了研發成本。許多醫療機構和研究機構面臨預算限制，阻礙了這些技術的大規模應用。植入手術和相關醫療基礎設施的高昂費用也使許多患者難以獲得這些技術。因此，成本方面的挑戰可能會延緩腦機介面技術的廣泛商業化。

與神經復健療法結合

腦機介面（BCI）系統與物理治療結合使用，可以幫助神經損傷或中風後喪失運動功能的患者恢復運動能力。透過機器人設備和虛擬介面將腦波訊號轉化為運動指令，患者可以重新訓練神經通路，進而改善復健效果。這種方法正受到全球復健中心和研究機構的廣泛關注。將BCI技術與機器人外骨骼和神經刺激技術結合，可以進一步增強治療效果。隨著復健醫學的進步，對整合式BCI解決方案的需求預計將快速成長。

醫療設備監管方面的挑戰

腦機介面（BCI）系統被認為是與人體神經系統直接互動的複雜醫療設備。因此，它們在商業化之前必須經過嚴格的安全評估、臨床試驗和監管核准。各國監管要求不盡相同，這可能會延緩產品開發和市場准入。遵守嚴格的安全標準和倫理考量進一步增加了核准流程的複雜性。這些監管障礙可能減緩創新，並限制新型BCI技術惠及病患的速度。

新冠疫情的影響：

新冠疫情對神經復健腦機介面（BCI）市場產生了複雜的影響。疫情初期，封鎖和限制措施暫時延緩了許多與BCI技術相關的臨床試驗和研究計劃。由於大量醫療資源被調配用於救治新冠患者，神經學研究活動受到影響。然而，疫情也提升了人們對遠端醫療技術和數位健康解決方案的興趣。研究人員探索了BCI系統在遠端患者監護和復健方面的新應用。隨著研究活動的恢復，對先進神經科學技術的投資持續成長。

在預測期內，電極細分市場預計將佔據最大的市場佔有率。

預計在預測期內，電極部分將佔據最大的市場佔有率。這是因為電極在腦機介面（BCI）系統中神經訊號的擷取和傳輸中起著至關重要的作用。這些元件是大腦與外部運算設備之間的主要介面。電極材料和設計的進步提高了訊號的準確性、耐用性和病人安全性。侵入式和非侵入式電極技術均已廣泛應用於研究和臨床領域。 BCI系統在神經系統疾病治療和研究中的日益普及，推動了對高性能電極的需求。

在預測期內，神經科學研究中心板塊預計將呈現最高的複合年成長率。

在預測期內，神經科學研究中心領域預計將呈現最高的成長率，這主要得益於腦科學研究和神經系統疾病研究投入的增加。研究機構正積極探索腦機介面（BCI）技術在揭示大腦功能和開發新治療方法的潛力。各國政府和學術機構正在資助大規模的神經科學舉措，以推動腦科學的發展。這些中心也與生技公司和醫療設備製造商合作，共同開發下一代BCI系統。先進研究基礎設施的完善也進一步促進了BCI技術的快速應用。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這主要得益於其強大的技術基礎設施和對神經科學研究的大量投入。該地區匯集了許多專注於神經工程領域的主要企業、研究機構和大學。政府撥款和私部門投資正大力支持腦機介面（BCI）的研發專案。此外，先進的醫療保健系統和創新醫療技術的早期應用也促進了市場成長。科技公司與醫療機構之間的合作進一步加速了BCI的創新。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於醫療保健投資的增加和神經科學研究活動的拓展。中國、日本、韓國和印度等國家正迅速增強其生物醫學研究能力。該地區各國政府正透過資助舉措和戰略夥伴關係支持醫療技術創新。神經系統疾病盛行率的上升也增加了對先進治療方案的需求。此外，醫療基礎設施和研究設施的改善正在加速腦機介面（BCI）技術的應用。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要企業進行SWOT分析（最多3家公司）
  • 區域分類
    • 應客戶要求，我們提供主要國家和地區的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對主要企業進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要企業市佔率分析
  • 產品基準評效和效能比較

第5章：全球神經修復腦機介面市場：依產品分類

  • 侵入式腦機介面系統
  • 部分侵入式腦機介面系統
  • 非侵入式腦機介面設備
  • 植入式神經介面
  • 穿戴式腦機介面系統
  • 其他產品

第6章 全球神經修復腦機介面市場：依組件分類

  • 電極
  • 神經放大器
  • 訊號處理設備
  • 軟體和演算法
  • 其他規則

第7章 全球神經修復腦機介面市場：依技術分類

  • 基於腦電圖的系統
  • ECo G 系統
  • 深部腦部刺激
  • 封閉回路型神經控制
  • 無線神經介面
  • 其他技術

第8章 全球神經修復腦機介面市場：依適應症分類

  • 脊髓損傷
  • 中風復健
  • 帕金森氏症
  • 癲癇
  • 其他跡象

第9章 全球神經修復腦機介面市場：依最終用戶分類

  • 醫院
  • 神經科學研究中心
  • 復健中心
  • 學術機構
  • 其他最終用戶

第10章 全球神經修復腦機介面市場：依地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第11章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第12章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第13章：公司簡介

  • Neuralink Corp.
  • Synchron, Inc.
  • Blackrock Neurotech
  • Medtronic plc
  • Abbott Laboratories
  • NeuroPace, Inc.
  • BrainCo, Inc.
  • Paradromics Inc.
  • G.TEC Medical Engineering GmbH
  • EMOTIV Inc.
  • Cochlear Ltd.
  • Natus Medical Incorporated
  • Kernel Inc.
  • Second Sight Medical Products
  • Cognixion
Product Code: SMRC34506

According to Stratistics MRC, the Global Neuro-Restorative Brain-Computer Interface (BCI) Market is accounted for $0.30 billion in 2026 and is expected to reach $0.96 billion by 2034 growing at a CAGR of 15.9% during the forecast period. Neuro-Restorative Brain-Computer Interfaces (BCIs) are technologies that create direct communication pathways between the brain and external devices to restore or enhance neurological function. These systems interpret neural signals and translate them into commands to control prosthetics, computers, or therapeutic stimulation devices. BCIs are designed to support patients with neurological conditions such as paralysis, spinal cord injuries, or neurodegenerative disorders. By enabling neural rehabilitation and restoring lost functions, neuro-restorative BCIs improve mobility, communication, and independence for patients while advancing research in neurotechnology and brain health.

Market Dynamics:

Driver:

Advances in neural interface technologies

Continuous improvements in neural signal acquisition, processing algorithms, and electrode design have enhanced the performance and reliability of BCI systems. These innovations enable more accurate communication between the human brain and external devices. Modern BCI systems are increasingly used to assist patients with neurological disorders such as paralysis, spinal cord injuries, and neurodegenerative diseases. Researchers are also developing minimally invasive and wireless neural interfaces that improve patient comfort and usability. As technological advancements continue, the effectiveness and adoption of neuro-restorative BCI solutions are expected to increase significantly.

Restraint:

High cost of BCI devices

Developing advanced neural interface systems requires sophisticated hardware, specialized materials, and complex software algorithms. Additionally, clinical testing and regulatory approval processes further increase development costs. Many healthcare providers and research institutions face budget constraints that limit large-scale adoption of these technologies. The high price of implantation procedures and associated medical infrastructure also restricts accessibility for many patients. As a result, cost-related challenges can slow the widespread commercialization of BCI technologies.

Opportunity:

Integration with neurorehabilitation therapies

BCI systems can be used alongside physical therapy to help patients regain lost motor functions after neurological injuries or strokes. By translating brain signals into movements through robotic devices or virtual interfaces, patients can retrain neural pathways and improve recovery outcomes. This approach is gaining attention in rehabilitation centers and research institutions worldwide. The combination of BCI technology with robotic exoskeletons and neurostimulation techniques further enhances treatment effectiveness. As rehabilitation medicine advances, the demand for integrated BCI solutions is expected to grow rapidly.

Threat:

Regulatory challenges for medical devices

BCI systems are considered complex medical devices that directly interact with the human nervous system. As a result, they must undergo rigorous safety evaluations, clinical trials, and regulatory approvals before commercialization. The regulatory requirements vary across different countries, which can delay product development and market entry. Compliance with strict safety standards and ethical considerations adds further complexity to the approval process. These regulatory hurdles may slow innovation and limit the speed at which new BCI technologies reach patients.

Covid-19 Impact:

The COVID-19 pandemic had a mixed impact on the Neuro-Restorative Brain-Computer Interface market. During the early stages of the pandemic, many clinical trials and research projects related to BCI technologies were temporarily delayed due to lockdowns and restrictions. Healthcare resources were largely redirected toward managing COVID-19 cases, affecting neurological research activities. However, the pandemic also increased interest in remote healthcare technologies and digital health solutions. Researchers explored new applications of BCI systems for remote patient monitoring and rehabilitation. As research activities resumed, investment in advanced neurological technologies continued to grow.

The electrodes segment is expected to be the largest during the forecast period

The electrodes segment is expected to account for the largest market share during the forecast period as electrodes play a crucial role in capturing and transmitting neural signals in BCI systems. These components serve as the primary interface between the brain and external computing devices. Advances in electrode materials and designs have improved signal accuracy, durability, and patient safety. Both invasive and non-invasive electrode technologies are widely used in research and clinical applications. The increasing adoption of BCI systems for neurological disorder treatment and research has boosted demand for high-performance electrodes.

The neuroscience research centers segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the neuroscience research centers segment is predicted to witness the highest growth rate due to increasing investments in brain research and neurological disorder studies. Research institutions are actively exploring the potential of BCI technologies to understand brain functions and develop new therapeutic approaches. Governments and academic organizations are funding large-scale neuroscience initiatives to advance brain science. These centers also collaborate with biotechnology and medical device companies to develop next-generation BCI systems. The availability of advanced research infrastructure further supports the rapid adoption of BCI technologies.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share owing to strong technological infrastructure and significant investments in neuroscience research. The region hosts many leading medical device companies, research institutions, and universities specializing in neural engineering. Government funding and private sector investments strongly support BCI development programs. Additionally, the presence of advanced healthcare systems and early adoption of innovative medical technologies contribute to market growth. Collaborations between technology firms and healthcare organizations further accelerate BCI innovation.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR driven by increasing healthcare investments and expanding neuroscience research activities. Countries such as China, Japan, South Korea, and India are rapidly developing their biomedical research capabilities. Governments across the region are supporting innovation in medical technologies through funding initiatives and strategic partnerships. The growing prevalence of neurological disorders is also increasing demand for advanced treatment solutions. Additionally, improvements in healthcare infrastructure and research facilities are encouraging the adoption of BCI technologies.

Key players in the market

Some of the key players in Neuro-Restorative Brain-Computer Interface (BCI) Market include Neuralink Corp., Synchron, Inc., Blackrock Neurotech, Medtronic plc, Abbott Laboratories, NeuroPace, Inc., BrainCo, Inc., Paradromics Inc., G.TEC Medical Engineering GmbH, EMOTIV Inc., Cochlear Ltd., Natus Medical Incorporated, Kernel Inc., Second Sight Medical Products and Cognixion.

Key Developments:

In June 2025, Neuralink introduced DataRepo, a multimodal data management platform. This tool is designed to handle complex datasets from BCI trials, enabling better integration of neural signals and clinical outcomes.

In November 2024, Synchron launched a new engineering hub in San Diego focused on building "the world's most advanced brain interface," signaling a significant expansion of its hardware engineering capabilities.

Products Covered:

  • Invasive BCI Systems
  • Partially Invasive BCI Systems
  • Non-Invasive BCI Devices
  • Implantable Neural Interfaces
  • Wearable BCI Systems
  • Other Products

Components Covered:

  • Electrodes
  • Neural Amplifiers
  • Signal Processors
  • Software & Algorithms
  • Other Components

Technologies Covered:

  • EEG-Based Systems
  • ECoG Systems
  • Deep Brain Stimulation
  • Closed-Loop Neuromodulation
  • Wireless Neural Interfaces
  • Other Technologies

Indications Covered:

  • Spinal Cord Injury
  • Stroke Rehabilitation
  • Parkinson's Disease
  • Epilepsy
  • Other Indications

End Users Covered:

  • Hospitals
  • Neuroscience Research Centers
  • Rehabilitation Centers
  • Academic Institutes
  • Other End Users

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Neuro-Restorative BCI Market, By Product

  • 5.1 Invasive BCI Systems
  • 5.2 Partially Invasive BCI Systems
  • 5.3 Non-Invasive BCI Devices
  • 5.4 Implantable Neural Interfaces
  • 5.5 Wearable BCI Systems
  • 5.6 Other Products

6 Global Neuro-Restorative BCI Market, By Component

  • 6.1 Electrodes
  • 6.2 Neural Amplifiers
  • 6.3 Signal Processors
  • 6.4 Software & Algorithms
  • 6.5 Other Components

7 Global Neuro-Restorative BCI Market, By Technology

  • 7.1 EEG-Based Systems
  • 7.2 ECoG Systems
  • 7.3 Deep Brain Stimulation
  • 7.4 Closed-Loop Neuromodulation
  • 7.5 Wireless Neural Interfaces
  • 7.6 Other Technologies

8 Global Neuro-Restorative BCI Market, By Indication

  • 8.1 Spinal Cord Injury
  • 8.2 Stroke Rehabilitation
  • 8.3 Parkinson's Disease
  • 8.4 Epilepsy
  • 8.5 Other Indications

9 Global Neuro-Restorative BCI Market, By End User

  • 9.1 Hospitals
  • 9.2 Neuroscience Research Centers
  • 9.3 Rehabilitation Centers
  • 9.4 Academic Institutes
  • 9.5 Other End Users

10 Global Neuro-Restorative BCI Market, By Geography

  • 10.1 North America
    • 10.1.1 United States
    • 10.1.2 Canada
    • 10.1.3 Mexico
  • 10.2 Europe
    • 10.2.1 United Kingdom
    • 10.2.2 Germany
    • 10.2.3 France
    • 10.2.4 Italy
    • 10.2.5 Spain
    • 10.2.6 Netherlands
    • 10.2.7 Belgium
    • 10.2.8 Sweden
    • 10.2.9 Switzerland
    • 10.2.10 Poland
    • 10.2.11 Rest of Europe
  • 10.3 Asia Pacific
    • 10.3.1 China
    • 10.3.2 Japan
    • 10.3.3 India
    • 10.3.4 South Korea
    • 10.3.5 Australia
    • 10.3.6 Indonesia
    • 10.3.7 Thailand
    • 10.3.8 Malaysia
    • 10.3.9 Singapore
    • 10.3.10 Vietnam
    • 10.3.11 Rest of Asia Pacific
  • 10.4 South America
    • 10.4.1 Brazil
    • 10.4.2 Argentina
    • 10.4.3 Colombia
    • 10.4.4 Chile
    • 10.4.5 Peru
    • 10.4.6 Rest of South America
  • 10.5 Rest of the World (RoW)
    • 10.5.1 Middle East
      • 10.5.1.1 Saudi Arabia
      • 10.5.1.2 United Arab Emirates
      • 10.5.1.3 Qatar
      • 10.5.1.4 Israel
      • 10.5.1.5 Rest of Middle East
    • 10.5.2 Africa
      • 10.5.2.1 South Africa
      • 10.5.2.2 Egypt
      • 10.5.2.3 Morocco
      • 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

  • 11.1 Industry Value Network and Supply Chain Assessment
  • 11.2 White-Space and Opportunity Mapping
  • 11.3 Product Evolution and Market Life Cycle Analysis
  • 11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

  • 12.1 Mergers and Acquisitions
  • 12.2 Partnerships, Alliances, and Joint Ventures
  • 12.3 New Product Launches and Certifications
  • 12.4 Capacity Expansion and Investments
  • 12.5 Other Strategic Initiatives

13 Company Profiles

  • 13.1 Neuralink Corp.
  • 13.2 Synchron, Inc.
  • 13.3 Blackrock Neurotech
  • 13.4 Medtronic plc
  • 13.5 Abbott Laboratories
  • 13.6 NeuroPace, Inc.
  • 13.7 BrainCo, Inc.
  • 13.8 Paradromics Inc.
  • 13.9 G.TEC Medical Engineering GmbH
  • 13.10 EMOTIV Inc.
  • 13.11 Cochlear Ltd.
  • 13.12 Natus Medical Incorporated
  • 13.13 Kernel Inc.
  • 13.14 Second Sight Medical Products
  • 13.15 Cognixion

List of Tables

  • Table 1 Global Neuro-Restorative BCI Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Neuro-Restorative BCI Market, By Product (2023-2034) ($MN)
  • Table 3 Global Neuro-Restorative BCI Market, By Invasive BCI Systems (2023-2034) ($MN)
  • Table 4 Global Neuro-Restorative BCI Market, By Partially Invasive BCI Systems (2023-2034) ($MN)
  • Table 5 Global Neuro-Restorative BCI Market, By Non-Invasive BCI Devices (2023-2034) ($MN)
  • Table 6 Global Neuro-Restorative BCI Market, By Implantable Neural Interfaces (2023-2034) ($MN)
  • Table 7 Global Neuro-Restorative BCI Market, By Wearable BCI Systems (2023-2034) ($MN)
  • Table 8 Global Neuro-Restorative BCI Market, By Other Products (2023-2034) ($MN)
  • Table 9 Global Neuro-Restorative BCI Market, By Component (2023-2034) ($MN)
  • Table 10 Global Neuro-Restorative BCI Market, By Electrodes (2023-2034) ($MN)
  • Table 11 Global Neuro-Restorative BCI Market, By Neural Amplifiers (2023-2034) ($MN)
  • Table 12 Global Neuro-Restorative BCI Market, By Signal Processors (2023-2034) ($MN)
  • Table 13 Global Neuro-Restorative BCI Market, By Software & Algorithms (2023-2034) ($MN)
  • Table 14 Global Neuro-Restorative BCI Market, By Other Components (2023-2034) ($MN)
  • Table 15 Global Neuro-Restorative BCI Market, By Technology (2023-2034) ($MN)
  • Table 16 Global Neuro-Restorative BCI Market, By EEG-Based Systems (2023-2034) ($MN)
  • Table 17 Global Neuro-Restorative BCI Market, By ECoG Systems (2023-2034) ($MN)
  • Table 18 Global Neuro-Restorative BCI Market, By Deep Brain Stimulation (2023-2034) ($MN)
  • Table 19 Global Neuro-Restorative BCI Market, By Closed-Loop Neuromodulation (2023-2034) ($MN)
  • Table 20 Global Neuro-Restorative BCI Market, By Wireless Neural Interfaces (2023-2034) ($MN)
  • Table 21 Global Neuro-Restorative BCI Market, By Other Technologies (2023-2034) ($MN)
  • Table 22 Global Neuro-Restorative BCI Market, By Indication (2023-2034) ($MN)
  • Table 23 Global Neuro-Restorative BCI Market, By Spinal Cord Injury (2023-2034) ($MN)
  • Table 24 Global Neuro-Restorative BCI Market, By Stroke Rehabilitation (2023-2034) ($MN)
  • Table 25 Global Neuro-Restorative BCI Market, By Parkinson's Disease (2023-2034) ($MN)
  • Table 26 Global Neuro-Restorative BCI Market, By Epilepsy (2023-2034) ($MN)
  • Table 27 Global Neuro-Restorative BCI Market, By Other Indications (2023-2034) ($MN)
  • Table 28 Global Neuro-Restorative BCI Market, By End User (2023-2034) ($MN)
  • Table 29 Global Neuro-Restorative BCI Market, By Hospitals (2023-2034) ($MN)
  • Table 30 Global Neuro-Restorative BCI Market, By Neuroscience Research Centers (2023-2034) ($MN)
  • Table 31 Global Neuro-Restorative BCI Market, By Rehabilitation Centers (2023-2034) ($MN)
  • Table 32 Global Neuro-Restorative BCI Market, By Academic Institutes (2023-2034) ($MN)
  • Table 33 Global Neuro-Restorative BCI Market, By Other End Users (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.